当前位置：药药网 / 药品研发 / 美国药品上市后承诺数据库
Odactra, House Dust Mites (Dermatophagoides farinae and Dermatophagoides pteronyssinus) Allergen Extract
药品名称
Odactra, House Dust Mites (Dermatophagoides farinae and Dermatophagoides pteronyssinus) Allergen Extract
承诺描述
Deferred pediatric study (Study 2) under PREA to evaluate the safety of ODACTRA in pediatric subjects 5 through 17 years with house dust mite induced allergic rhinitis/rhinoconjunctivitis with or without asthma.
承诺状态描述
The study has not been initiated, but does not meet the criterion for delayed.